Coventry University Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Cardiff University Featured PhD Programmes
"pluripotent"×
10 miles

pluripotent PhD Projects, Programs & Scholarships

We have 31 pluripotent PhD Projects, Programs & Scholarships

  • "pluripotent" ×
  • clear all
Order by 
Showing 1 to 10 of 31
  How does epithelial tissue organization modulate pluripotent stem cell identity and fate?
  Dr M Shahbazi
Application Deadline: 3 December 2019

Funding Type

PhD Type

During embryogenesis pluripotent stem cells give rise to all the cell types present in the organism. How pluripotent cells decide their fate is a fundamental question in development and regeneration.
  Modeling differentiation of human embryonic stem cells and induced pluripotent stem cells into endodermal derivatives
  Prof A Adamo
Applications accepted all year round

Funding Type

PhD Type

The Laboratory of Stem Cells and Diseases (STEMD-Lab) is seeking a highly motivated candidate to develop a project based on the use of human embryonic stem cells (hES) and induced pluripotent stem cells (iPSCs) to derive glucose sensitive differentiated cell types (i.e.
  Regulation of autophagy in human embryonic stem cells and its therapeutic application in induced pluripotent stem cell-based disease models
  Dr S Sarkar
Applications accepted all year round

Funding Type

PhD Type

Project background. Regulation of proteostasis is critical for maintaining tissue homeostasis. Autophagy, a major intracellular degradation pathway essential for cellular and energy homeostasis, functions in the clearance of aggregation-prone proteins and damaged organelles.
  Using gene editing and pluripotent stem cells to investigate cardiovascular cell signalling (SMITHU20DTP)
  Dr J Smith, Prof A E Munsterberg
Application Deadline: 25 November 2019

Funding Type

PhD Type

The heart is a multi-cellular organ, with intercellular communication between cardiomyocytes, cardiac fibroblasts, and endothelial cells all necessary to maintain normal cardiac function.
  Developing pluripotent stem cell models of inherited retinal diseases
  Prof C A Johnson
Applications accepted all year round

Funding Type

PhD Type

Background. Inherited retinal dystrophies are a leading cause of blindness and visual loss in the UK working age population. However, despite the widespread diagnostic use of next-generation sequencing, a molecular genetic diagnosis is unavailable for many patients world-wide.
  Developing a therapy for hearing loss using human pluripotent stem cells
  Prof M Rivolta
Applications accepted all year round

Funding Type

PhD Type

The vast majority of cases of deafness are produced by the irreversible loss of the sensory hair cells and their associated neurons.
  In vitro models of type 1 diabetes.
  Prof E Stanley
Applications accepted all year round

Funding Type

PhD Type

Type 1 diabetes is a condition in which the immune system destroys the cells that produce insulin, the hormone controlling the level of glucose in the blood stream.
  Investigating the function of developmental regulators in early human embryogenesis and stem cells
  Dr K Niakan
Application Deadline: 12 November 2019

Funding Type

PhD Type

This 4-year PhD studentship is offered in Dr Kathy Niakan’’s Group based at the Francis Crick Institute (the Crick). This project will characterise key regulators of human embryogenesis.
  Early lineage specification in mammalian embryos
  Dr B Plusa
Applications accepted all year round

Funding Type

PhD Type

Growing understanding of the pre-implantation mammalian development resulted in significant advances in assisted reproduction techniques and in regenerative medicine field.
  Molecular mechanisms regulating the developmental plasticity of pancreatic cancer cells #NDORMS-2020/6
  Dr S Pauklin
Application Deadline: 10 January 2020

Funding Type

PhD Type

Pancreatic cancers are among the most lethal malignancies in human due to highly metastatic characteristics and the poor responsiveness to currently used cancer therapeutics.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.